about
Genetic signature of histiocytic sarcoma revealed by a sleeping beauty transposon genetic screen in miceLethal small bowel necrosis due to aspergillosis during acute promyelocytic leukemia inductionTransformed large B-cell lymphoma in rituximab-allergic patient with chronic lymphocytic leukemia after allogeneic stem cell transplant: successful treatment with ofatumumabProfiling bortezomib resistance identifies secondary therapies in a mouse myeloma model.Loss of UHRF2 expression is associated with human neoplasia, promoter hypermethylation, decreased 5-hydroxymethylcytosine, and high proliferative activity.Marked Variability in Reported Minimal Residual Disease Lower Level of Detection of 4 Hematolymphoid Neoplasms: A Survey of Participants in the College of American Pathologists Flow Cytometry Proficiency Testing Program.Anaplastic mast cell sarcoma: a unique pathologic entity in mastocytosis.
P50
Q27332453-F7E3EFAF-77C4-4F14-9296-C0DC478EE6E6Q35116492-FFDB9C41-8E22-4359-99B9-00D2CEFFFCA2Q35129411-C1107812-49AE-47B9-998E-76FA29F9F551Q39174431-D104ABC9-0148-4E2D-98D4-30FB63A4B770Q41958274-CCB89F83-F0A4-44BB-9C38-31A74B06FD5FQ46608832-FA840DC1-AB7E-466D-9F72-8F0B3F55E9B9Q52838792-32A8F884-A1F7-4ED2-A002-50B7BF3063F2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael A. Linden
@ast
Michael A. Linden
@en
Michael A. Linden
@es
Michael A. Linden
@nl
Michael A. Linden
@sl
type
label
Michael A. Linden
@ast
Michael A. Linden
@en
Michael A. Linden
@es
Michael A. Linden
@nl
Michael A. Linden
@sl
prefLabel
Michael A. Linden
@ast
Michael A. Linden
@en
Michael A. Linden
@es
Michael A. Linden
@nl
Michael A. Linden
@sl
P106
P1153
35831210100
P21
P31
P496
0000-0002-7433-1676